Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition.

Research (Washington, D.C.)·2026
Same author

Recombinant Japanese Encephalitis Virus Envelope Antigen Presented on CoPoP Liposomes Elicits Cellular Immunity and Protects Mice From Lethal Challenge.

Immune network·2026
Same author

DeepDrugs: a mechanism-aware tri-linear attention framework for synergistic drug-combination prediction.

Briefings in bioinformatics·2026
Same author

Advances in IL-2 Family Cytokine-Based Cancer Therapies: Overcoming Challenges Through Molecular Engineering and Delivery Strategies.

Immune network·2026
Same author

Astragalus membranaceus sprouts and their unique constituents regulate reactive oxygen species production, inflammation-related senescence-associated secretory phenotype components, and extracellular matrix in fibroblasts.

Food research international (Ottawa, Ont.)·2026
Same author

Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer.

Translational research : the journal of laboratory and clinical medicine·2026

Related Experiment Video

Updated: Jan 13, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

889

Viral transduction for T cell engineering in immunotherapy.

Yikhyeon Seo1, Jimin Pak1, Jiyun Han1

  • 1School of Biological Sciences, Seoul National University, Gwanak-ro 1, Seoul 08826, Republic of Korea; Institute of Molecular Biology and Genetics, Seoul National University, Gwanak-ro 1, Seoul 08826, Republic of Korea.

Molecules and Cells
|January 6, 2026
PubMed
Summary

Viral transduction allows genetic engineering of primary T cells for research and immunotherapy. This guide helps researchers overcome challenges in T cell culture for successful genetic modification and cell expansion.

Keywords:
CAR-TImmunotherapyLentiviral transductionRetroviral transductionT cell engineering

More Related Videos

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
11:50

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function

Published on: November 4, 2016

11.5K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K

Related Experiment Videos

Last Updated: Jan 13, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

889
Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
11:50

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function

Published on: November 4, 2016

11.5K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.7K

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Viral transduction is a key method for the genetic engineering of primary T cells.
  • This technique supports applications in basic research and the development of immunotherapies.
  • Primary T cell culture presents unique challenges compared to standard cell lines due to activation and proliferation states.

Purpose of the Study:

  • To provide practical guidance on viral transduction of primary T cells.
  • To address the specific requirements and challenges associated with primary T cell culture.
  • To assist researchers new to T cell manipulation but experienced in mammalian cell culture.

Main Methods:

  • The article outlines a workflow for viral transduction applicable to primary T cells.
  • It details considerations for T cell activation, culture, and transduction.
  • Guidance is provided on optimizing conditions for efficient genetic engineering.

Main Results:

  • Successful viral transduction enables stable genetic modification of primary T cells.
  • The methods described aim to overcome common hurdles in T cell culture.
  • Researchers can achieve sufficient numbers of genetically engineered T cells for downstream applications.

Conclusions:

  • Viral transduction is a powerful tool for T cell genetic engineering.
  • Understanding T cell-specific culture nuances is crucial for success.
  • This guidance facilitates the application of T cell engineering in research and therapy.